Scandinavian Medical Solutions A/S (CPH:SMSMED)
3.070
+0.010 (0.33%)
Jul 28, 2026, 4:48 PM CET
CPH:SMSMED Ratios and Metrics
Market cap in millions DKK. Fiscal year is October - September.
Millions DKK. Fiscal year is Oct - Sep.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 28, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
| 85 | 110 | 182 | 270 | 118 | - | |
Market Cap Growth | -33.98% | -39.14% | -32.71% | 128.89% | - | - |
Enterprise Value | 157.9 | 171.85 | 209.76 | 290.43 | 90.19 | 0 |
Last Close Price | 3.07 | 3.99 | 6.60 | 10.30 | 4.50 | - |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 28, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
PE Ratio | - | - | 23.57 | 22.89 | 10.47 | - |
Forward PE | 61.40 | 11.48 | - | - | - | - |
PS Ratio | 0.40 | 0.45 | 0.80 | 1.41 | 1.07 | - |
PB Ratio | 1.17 | 1.34 | 2.20 | 3.62 | 1.90 | - |
P/TBV Ratio | 1.17 | 1.33 | 2.20 | 3.78 | 1.93 | - |
P/OCF Ratio | - | - | 53.51 | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 28, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
EV/Sales Ratio | 0.73 | 0.70 | 0.93 | 1.52 | 0.82 | - |
EV/EBITDA Ratio | 53.20 | 16.34 | 9.98 | 13.78 | 5.88 | - |
EV/EBIT Ratio | - | 96.06 | 15.25 | 17.47 | 6.12 | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 28, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Debt / Equity Ratio | 0.41 | 0.69 | 0.43 | 0.34 | 0.00 | 0 |
Debt / EBITDA Ratio | 13.11 | 6.04 | 1.87 | 1.36 | 0.01 | - |
Net Debt / Equity Ratio | 0.51 | 0.74 | 0.34 | 0.28 | -0.44 | -1.05 |
Net Debt / EBITDA Ratio | 12.63 | 5.84 | 1.34 | 0.98 | -1.80 | -2.33 |
Net Debt / FCF Ratio | -1.59 | -1.79 | -1.87 | -0.42 | 1.14 | -6.31 |
Asset Turnover | 1.09 | 1.29 | 1.34 | 1.42 | 1.47 | 2.32 |
Inventory Turnover | 1.86 | 2.17 | 2.19 | 2.20 | 2.43 | 5.85 |
Quick Ratio | 0.32 | 0.35 | 0.47 | 0.41 | 0.90 | 1.37 |
Current Ratio | 1.46 | 1.56 | 1.57 | 1.60 | 2.30 | 2.16 |
Return on Equity (ROE) | -10.49% | 0.03% | 9.92% | 17.89% | 26.36% | 56.28% |
Return on Assets (ROA) | -2.67% | 0.11% | 6.29% | 9.53% | 15.12% | 27.27% |
Return on Invested Capital (ROIC) | -4.75% | 0.17% | 10.33% | 19.85% | 68.57% | - |
Return on Capital Employed (ROCE) | -6.32% | 1.69% | 14.56% | 21.06% | 32.79% | 75.02% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 28, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Earnings Yield | - | 0.00% | 4.24% | 4.37% | 9.56% | - |
Payout Ratio | - | 0.00% | 0.00% | 0.00% | 0.00% | 55.39% |
Buyback Yield / Dilution | -0.61% | -0.67% | -0.57% | -2.22% | -707.62% | -3207.00% |
Total Shareholder Return | -0.61% | -0.67% | -0.57% | -2.22% | -707.62% | -3207.00% |